DR. I. Vanhoutte, radiotherapie-oncologie
0683.757.552 · rovalta.com · 28/09/2026
ACTIVE
DR. I. Vanhoutte, radiotherapie-oncologie
Financial year 2025 · Closed on 31/12/2025
Net result713,4 k €+181,9 %over 1 year
Gross margin1,1 M €+164,2 %over 1 year
Equity18,6 k €-96,8 %over 1 year
Overview
Identity
Source · BCE/KBODR. I. Vanhoutte, radiotherapie-oncologie is a Private limited company incorporated in 2017. Its registered office is in Gent.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0683.757.552
- Incorporation
- 26/10/2017
- Legal form
- Private limited company
- Registered office
- De Pintelaan 337
9000 Gent · FlandreSee on map - Contributed capital
- 18 550,00 €
- Latest accounts
- 31/12/2025
Signals
ProfitablePositive cashflowPositive EBITDA
Financials
Source · NBB, 8 filingsTrend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 1,1 M € | +164% | 400,6 k € | +80.3% | 222,2 k € | +20.1% | 185 k € | +47.8% | 125,2 k € |
| EBITDA | 1,1 M € | +165% | 399,1 k € | +80.6% | 221 k € | +20.2% | 183,9 k € | +74.4% | 105,5 k € |
| Operating result | 949,5 k € | +184% | 334,4 k € | +104% | 164 k € | +19.1% | 137,7 k € | +136% | 58,4 k € |
| Net result | 713,4 k € | +182% | 253 k € | +101% | 126,1 k € | +14.5% | 110,1 k € | +141% | 45,6 k € |
| Balance sheet | |||||||||
| Equity | 18,6 k € | -96.8% | 585,6 k € | +29.4% | 452,6 k € | -5.0% | 476,4 k € | +2.2% | 466,3 k € |
| Total assets | 768,8 k € | +28.9% | 596,3 k € | +26.3% | 472,1 k € | -17.5% | 572,6 k € | +21.7% | 470,6 k € |
| Cash | 168 k € | -7.9% | 182,5 k € | +476% | 31,7 k € | -64.9% | 90,2 k € | -4.8% | 94,7 k € |
| Debts | 750,2 k € | +6954% | 10,6 k € | -45.6% | 19,5 k € | -79.7% | 96,2 k € | +2164% | 4,2 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Ilse Vanhoutte | Directorsince 26/10/2017BestuurderendedManagerended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/06/2026 | 09/07/2025 | 16/07/2024 | 28/08/2023 | 30/08/2022 | 26/08/2021 |
| General meeting | 28/06/2026 | 30/06/2025 | 08/07/2024 | 24/08/2023 | 25/08/2022 | 25/08/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 8 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 28/06/2026 | 29/06/2026 | Dutch | |
| Micro model | 31/12/2024 | 30/06/2025 | 09/07/2025 | Dutch | |
| Micro model | 31/12/2023 | 08/07/2024 | 16/07/2024 | Dutch | |
| Micro model | 31/12/2022 | 24/08/2023 | 28/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 25/08/2022 | 30/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 25/08/2021 | 26/08/2021 | Dutch | |
| Micro model | 31/12/2019 | 20/06/2020 | 16/07/2020 | Dutch | |
| Micro model | 31/12/2018 | 21/08/2019 | 23/08/2019 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Ilse Vanhoutte | Directorsince 26/10/2017BestuurderendedManagerended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other24/11/2022STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN
- Mandates27/10/2022STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DIVERSEN - ONTSLAGEN - BENOEMINGEN
- Other23/03/2018DIVERSEN
- Other30/10/2017RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings5 filings
Mandates
Ilse Vanhoutte
2017201820192020202120222023202420252026
DR. I. Vanhoutte, radiotherapie-oncologie
De Pintelaan 337, 9000 Gent
Director
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| De Pintelaan 337, 9000 GentCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00237173 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| DR. I. Vanhoutte, radiotherapie-oncologieCurrent | accounts 2018 → 2025 | Accounts 2025 · 2026-00237173 |
Events
- 2025Annual accounts 2025713,4 k €↑
- 2024Annual accounts 2024253 k €↑
- 2023Annual accounts 2023126,1 k €↑
- 2022Annual accounts 2022110,1 k €↑
- 2021Annual accounts 202145,6 k €
- 26/10/2017IncorporationPrivate limited company